Chimeric antigen receptor T‐cell therapy in secondary central nervous system lymphoma: A multicenter analysis-Reference-Cited by-同舟云学术

Chimeric antigen receptor T‐cell therapy in secondary central nervous system lymphoma: A multicenter analysis

Published:2024-05-20 Issue:8 Volume:99 Page:1624-1627
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:American J Hematol

Author:

Alsouqi Aseel¹^ORCID,Ahmed Gulrayz²,Wang Juntian³,Cassanello Giulio⁴⁵,Szabo Aniko³,Rojek Alexandra E.⁶,Riedell Peter A.⁶,Awan Farrukh⁷^ORCID,Samples Laura⁸,Shadman Mazyar⁸^ORCID,Hu Marie⁹^ORCID,Bachanova Veronika⁹^ORCID,Wesson William¹⁰,Ahmed Nausheen¹⁰,Iqbal Madiha¹¹^ORCID,Kharfan‐Dabaja Mohamed A.¹¹^ORCID,Scordo Michael⁴,Johnson P. Connor¹²,Chen Yi‐Bin¹²,Ito Sawa¹^ORCID,Hamadani Mehdi²,Frigault Matthew¹²

Affiliation:

1. Division of Hematology and Oncology University of Pittsburgh Medical Center Pittsburgh Pennsylvania USA

2. BMT & Cellular Therapy Program Medical College of Wisconsin Milwaukee Wisconsin USA

3. Division of Biostatistics Medical College of Wisconsin Milwaukee Wisconsin USA

4. Adult Bone Marrow Transplant Service, Cellular Therapy Service, Department of Medicine Memorial Sloan Kettering Cancer Center New York New York USA

5. Department of Oncology and Onco‐hematology University of Milan Milan Italy

6. David and Etta Jonas Center for Cellular Therapy University of Chicago Chicago Illinois USA

7. Harold C. Simmons Comprehensive Cancer Center University of Texas Southwestern Medical Center Dallas Texas USA

8. Clinical Research Division Fred Hutchinson Cancer Center Seattle Washington USA

9. Division of Hematology, Oncology and Transplantation University of Minnesota Minneapolis Minnesota USA

10. Division of Hematologic Malignancies and Cellular Therapy University of Kansas Cancer Center Kansas City Kansas USA

11. Division of Hematology and Medical Oncology Mayo Clinic Jacksonville Florida USA

12. Hematopoietic Cell Transplant and Cellular Therapy Program Massachusetts General Hospital – Harvard Medical School Boston Massachusetts USA

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ajh.27354

Reference6 articles.

1. Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma

2. Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification

3. Report of an International Workshop to Standardize Baseline Evaluation and Response Criteria for Primary CNS Lymphoma

4. ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells

5. Outcomes of patients with secondary central nervous system lymphoma following CAR T-cell therapy: a multicenter cohort study